Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Jan
31
2020
HazCom/GHS - Labelling – Multi-Jurisdictional Labels - Different Classification OR Supplemental Information Keller and Heckman LLP
Jan
31
2020
McDermottPlus Check-Up: January 31, 2020 McDermott Will & Emery
Jan
31
2020
Comments on Chapter 14: Recall Plan of FDA’s Draft Guidance on Human HARPC Rule Due February 4 Keller and Heckman LLP
Jan
30
2020
DEA’s National Drug Threat Assessment Shows Marijuana Potency and Demand Increasing; Black Market Operations Thriving Jackson Lewis P.C.
Jan
30
2020
USDA’s Hemp Production Program Advances Squire Patton Boggs (US) LLP
Jan
30
2020
OIG Advisory Opinion Permits a Pharmaceutical Manufacturer to Provide Financial Assistance to Needy Patients Receiving Risky Cell Therapy Mintz
Jan
30
2020
Nestle Asks California District Court to Dismiss Class Action Lawsuit Claiming that Nestle Knowingly Sold Coffee Creamer Containing Trans Fat to Consumers Keller and Heckman LLP
Jan
30
2020
Comments on EPA’s Draft Risk Evaluation of Carbon Tetrachloride Due March 27, 2020 Bergeson & Campbell, P.C.
Jan
29
2020
Inherent Claim Limitation Necessarily Present in the Prior Art Invalidates Patent McDermott Will & Emery
Jan
29
2020
DOJ Announces Settlement with EHR Company to Resolve Criminal and Civil Kickback Investigations Tied to Opioid Prescribing Robinson & Cole LLP
Jan
29
2020
No En Banc Review of Non-Institution Decision After Remand of Partial Institution McDermott Will & Emery
Jan
29
2020
Up in Smoke: TCPA Class Action against Cannabis Delivery Company Wacked on Numerosity Grounds Squire Patton Boggs (US) LLP
Jan
29
2020
Like Numerous Other States, Kansas Bill Would Prohibit Labeling Plant-Based Products as “Meat” Without Disclaimer Keller and Heckman LLP
Jan
29
2020
House Members Strongly Urge Senate Banking Committee to Make “Legal” Cannabis SAFE for Banking Carlton Fields
Jan
28
2020
DOJ Reaches Settlement with Patient Assistance Foundation Resolving Allegations of FCA Violations Robinson & Cole LLP
Jan
28
2020
FDA User Fees: How Do They Work? Mintz
Jan
28
2020
EPA Lists 160 PFAS for EPCRA Toxics Release Reporting Steptoe & Johnson PLLC
Jan
28
2020
Five Tips for Landlords of Cannabis-Related Businesses ArentFox Schiff LLP
Jan
28
2020
Senate Refers Sustainable Chemistry Research and Development Act of 2019 to Committee on Commerce, Science, and Transportation Bergeson & Campbell, P.C.
Jan
27
2020
Close Scrutiny for Class Settlements Where Plaintiff Attorneys Take Lion’s Share McDermott Will & Emery
Jan
27
2020
Medicare Fraud Uncovered by Multiple Whistleblowers Kohn, Kohn & Colapinto
Jan
27
2020
Risks Remain for Banks Servicing the Hemp Industry ArentFox Schiff LLP
Jan
27
2020
EPA Lists FIFRA-Registered Products Covered by Generic Data Call-In for Nanosilver Bergeson & Campbell, P.C.
Jan
27
2020
Recap of Our Health Law and Policy Year-in-Review Posts for 2019 Mintz
Jan
27
2020
Proposed Class Action Lawsuit Alleges “Just a Tad Sweet” is an Unauthorized and Misleading Low Sugar Claim for Honest Tea Beverages Keller and Heckman LLP
Jan
25
2020
NNCO Will Hold Workshops, Webinars, and Meetings in 2020 Bergeson & Campbell, P.C.
Jan
24
2020
Second Time’s a Charm? Governor Cuomo Introduces New Legislation to Regulate Adult-Use Cannabis in New York State Wilson Elser Moskowitz Edelman & Dicker LLP
Jan
24
2020
DOT Random Drug and Alcohol Testing Rates for 2020 Jackson Lewis P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins